|4Jan 18, 4:19 PM ET

Barton Russell 4

4 · Acumen Pharmaceuticals, Inc. · Filed Jan 18, 2023

Insider Transaction Report

Form 4
Period: 2023-01-17
Barton Russell
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2023-01-17+26,70026,700 total
  • Award

    Employee Stock Option (right to buy)

    2023-01-17+120,200120,200 total
    Exercise: $6.11Exp: 2033-01-16Common Stock (120,200 underlying)
Footnotes (2)
  • [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.
  • [F2]The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION